EyePoint Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
18 Apr 24 | BuyUS$10,489,446 | Cormorant Asset Management, LP | Company | 581,765 | US$18.90 | |
24 Jan 24 | SellUS$874,200 | Nancy Lurker | Individual | 35,000 | US$24.98 | |
11 Jan 24 | BuyUS$17,051,100 | Cormorant Asset Management, LP | Company | 855,000 | US$21.32 | |
11 Jan 24 | SellUS$37,159,225 | Ocumension Therapeutics | Company | 1,910,500 | US$19.45 | |
08 Dec 23 | BuyUS$9,999,995 | Cormorant Asset Management, LP | Company | 588,235 | US$17.00 | |
06 Dec 23 | SellUS$19,510,637 | Ocumension Therapeutics | Company | 1,000,000 | US$19.91 | |
06 Dec 23 | SellUS$23,439,049 | Essex Woodlands Management, Inc. | Company | 1,153,135 | US$22.04 | |
04 Dec 23 | BuyUS$29,113,332 | Cormorant Asset Management, LP | Company | 1,469,353 | US$21.87 | |
04 Dec 23 | SellUS$415,200 | Nancy Lurker | Individual | 20,000 | US$20.76 | |
04 Dec 23 | SellUS$20,790 | Michael Pine | Individual | 1,000 | US$20.79 | |
04 Dec 23 | BuyUS$12,760,818 | Cormorant Asset Management, LP | Company | 449,704 | US$34.49 | |
01 Sep 23 | SellUS$197,982 | Essex Woodlands Management, Inc. | Company | 20,000 | US$9.90 | |
31 Aug 23 | SellUS$1,467,698 | Essex Woodlands Management, Inc. | Company | 139,471 | US$11.36 | |
29 Aug 23 | SellUS$1,700,668 | Essex Woodlands Management, Inc. | Company | 146,357 | US$11.71 | |
28 Aug 23 | SellUS$25,298 | Essex Woodlands Management, Inc. | Company | 2,355 | US$10.74 | |
25 Aug 23 | SellUS$2,538,747 | Essex Woodlands Management, Inc. | Company | 223,936 | US$11.54 | |
23 Aug 23 | SellUS$2,264,748 | Essex Woodlands Management, Inc. | Company | 167,881 | US$14.62 | |
30 May 23 | SellUS$6 | Ocumension Therapeutics | Company | 1 | US$6.00 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 4,724 | 0.00846% |
Public Companies | 100,221 | 0.179% |
Individual Insiders | 469,775 | 0.841% |
VC/PE Firms | 3,095,136 | 5.54% |
Hedge Funds | 16,688,146 | 29.9% |
Institutions | 35,487,063 | 63.5% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 51.8%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
7,475,000 | US$131.6m | 23.8% | 7.05% | |||
5,156,299 | US$90.8m | 15.5% | 0.17% | |||
4,598,127 | US$80.9m | 11.9% | 0.03% | |||
4,081,379 | US$71.8m | 197% | 0.01% | |||
4,056,847 | US$71.4m | 16.2% | 2.96% | |||
3,095,136 | US$54.5m | -8.17% | 0.72% | |||
2,337,786 | US$41.1m | -33% | 13.51% | |||
2,169,306 | US$38.2m | 18.6% | no data | |||
2,034,060 | US$35.8m | 41.2% | no data | |||
1,536,125 | US$27.0m | 14,700% | 0.01% | |||
1,227,278 | US$21.6m | 15.9% | 0.02% | |||
1,208,873 | US$21.3m | 1,620% | no data | |||
1,128,638 | US$19.9m | 94.4% | 0.02% | |||
1,066,240 | US$18.8m | 0% | 0.01% | |||
770,503 | US$13.6m | 3,440% | 0.01% | |||
682,417 | US$12.0m | 27.4% | no data | |||
674,824 | US$11.9m | 194% | 0.03% | |||
633,409 | US$11.1m | 0% | 0.39% | |||
589,646 | US$10.4m | 0% | 0.23% | |||
574,169 | US$10.1m | 8.98% | no data | |||
550,609 | US$9.7m | 3.29% | no data | |||
541,530 | US$9.5m | -6.01% | no data | |||
425,128 | US$7.5m | 41.7% | 4.92% | |||
401,557 | US$7.1m | 0% | 9.78% | |||
400,000 | US$7.0m | 0% | 0.07% |